OTC Markets OTCPK - Delayed Quote USD

Rafarma Pharmaceuticals, Inc. (RAFA)

0.0800

0.0000

(0.00%)

As of April 25 at 4:00:00 PM EDT. Market Open.

Life Science Virtual Investor Forum: Presentations Now Available for Online Viewing

Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.comNEW YORK, March 14, 2025 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the presentations from the Life Science Virtual Investor Forum, held March 13th are now available for online viewing. REGISTER NOW AT: https://bit.ly/3DIWqav The company presentations will be available 24/7 for 90 days. Investors, advisors, and analysts may download

GlobeNewswire last month

PDSB

TELIF

BPTSY
Life Sciences Investor Forum Agenda Announced for March 13th

Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.comNEW YORK, March 12, 2025 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series announced the agenda for the Life Sciences Investor Forum March 13th. This event is co-hosted by Zacks Small Cap Research. Individual investors, institutional investors, advisors, and analysts are invited to attend. REGISTER NOW AT: https://bit.ly/4hnure6 It is recommended that inve

GlobeNewswire last month

NGENF

BPTSY

HMTXF
Rafarma Pharmaceuticals to Present at the Virtual Life Science Investor Forum March 13th

Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.comNEW YORK, March 12, 2025 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals] (Pink:Rafa), based in Wyoming, focused on Radiopharmaceuticals and anti cancer nuclear medicine, today announced that Liza Babenko, Press secretary, will present live at the Virtual Life Science Investor Forum hosted by VirtualInvestorConferences.com, on March 13th, 2025. DATE: March 13th

GlobeNewswire last month

RAFA
0.00%
Rafarma pharmaceutical updates

Sheridan, Wyoming, USA, Dec. 18, 2024 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals (OTC: RAFA) Dear Rafarma shareholders, We apologize for the delay in providing information about the company's activities in recent months. The past months have been truly transformational for us. And the company transformations that we are going through now will bring a long-awaited update for the company in the new year. “Everything that does not kill us makes us stronger,” said the German philosopher Nietzsche b

GlobeNewswire 4 months ago

RAFA
0.00%
Rafarma pharmaceutical updates: registration of Rafarma microspheres in South Korea

Sheridan, Wyoming, USA, July 04, 2024 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals (OTC: RAFA) - Rafarma Pharmaceuticals is pleased to announce its participation in the scientific conference on radioembolization using Yttrium 90 microspheres for the treatment of cancer at Severance Hospital in Seoul, South Korea. It is one of the largest university hospitals in South Korea and is of strategic importance to the country. Currently, procedure is underway to register Yttrium 90 microspheres produced

GlobeNewswire 9 months ago

RAFA
0.00%
Rafarma pharmaceutical updates: creation of a joint research and production enterprise in Busan (South Korea) between Rafarma and the Korean pharmaceutical company Woods Medical Care

Sheridan, Wyoming, USA, July 03, 2024 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals (OTC: RAFA) - Rafarma Pharmaceuticals is pleased to announce the signing of a preliminary agreement to establish a joint industrial venture in Busan Technology Park (South Korea) as the Dongnam Industrial Park of Radiological & Medical Sciences. The partners in the venture are Rafarma and the Korean pharmaceutical company Woods Medical Care. Woods Medical Care, Inc. was established to grow into a global pharmaceuti

GlobeNewswire 9 months ago

RAFA
0.00%

Performance Overview

Return	RAFA	S&P 500 (^GSPC)
YTD	+3.90%	-6.07%
1-Year	-27.93%	+8.32%
3-Year	-88.39%	+28.85%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Rafarma Pharmaceuticals, Inc. (RAFA)

Life Science Virtual Investor Forum: Presentations Now Available for Online Viewing

Life Sciences Investor Forum Agenda Announced for March 13th

Rafarma Pharmaceuticals to Present at the Virtual Life Science Investor Forum March 13th

Rafarma pharmaceutical updates

Rafarma pharmaceutical updates: registration of Rafarma microspheres in South Korea

Rafarma pharmaceutical updates: creation of a joint research and production enterprise in Busan (South Korea) between Rafarma and the Korean pharmaceutical company Woods Medical Care

Performance Overview